Navigation Links
First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
Date:3/16/2009

WASHINGTON, DCGenetic researchers at Children's National Medical Center and the National Center of Neurology and Psychiatry in Tokyo published the results of the first successful application of "multiple exon-skipping" to curb the devastating effects of Duchenne muscular dystrophy in an animal larger than a mouse. Multiple exon-skipping employs multiple DNA-like molecules as a "DNA band-aids" to skip over the parts of the mutated gene that block the effective creation of proteins.

The study, conducted in Japan and the United States, published this month in the peer-reviewed journal of the American Neurological Association, the Annals of Neurology, treated dogs with naturally occurring canine X-linked muscular dystrophy, a disease which is genetically homologous to the Duchenne muscular dystrophy that strikes 1 of every 3,500 boys born in the United States and worldwide each year.

Duchenne muscular dystrophy, one of the most common lethal genetic disorders, is an X-linked genetic mutation that causes an inability of the body's cells to effectively create dystrophinwhich builds muscle tissue. "Exon-skipping" employs synthetic DNA-like molecules called antisense as a DNA band-aid to skip over the parts of the gene that block the effective creation of dystrophin. Because the gene's mutation could affect any of its 79 exons and sometimes more than one single exon at a time, scientists employed a "cocktail" of antisense called morpholinos to extend the range of this application. By skipping more than a single exon, this so-called DNA band-aid becomes applicable to between 80 and 90 percent of Duchenne muscular dystrophy patients, including the mutation foun
'/>"/>

Contact: Jennifer Leischer
jleische@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids
2. ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards
3. Young Onset Parkinson Conferences: A First-Ever Collaboration
4. First DHI-Licensed Door Inspection Software Solution Ships to DOORDATA Solutions' Charter Members
5. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
6. Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
7. First Rewards Paid to New Jersey Doctors Through Participation in Bridges to Excellence
8. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
9. BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
10. Yankees Will Become First MLB Team to Integrate Highly Advanced Antimicrobial System
11. Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... (HealthDay News) -- Just a few extra cups of ... an autoimmune liver disease known as primary sclerosing cholangitis ... Mayo Clinic in Rochester, Minn., found that drinking coffee ... disease, which can lead to cirrhosis of the liver, ... not prove a cause-and-effect relationship. "While rare, ...
(Date:5/18/2013)... 18, 2013) There are significant cost and ... to diagnose or treat gastrointestinal problems, according to ... , A study by New York Presbyterian Hospital ... testing may substantially reduce the cost and risk ... is believed to affect nearly 25 percent of ...
(Date:5/18/2013)... ID (PRWEB) May 18, 2013 ... when it comes to safety and comfort of ... requirements and provides clients with an effective and ... This is an integrated, turnkey communications solution ... care, while allowing residents independence and privacy. ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Transvaginal ... products continue to move forward in a consolidated litigation ... Liebhard LLP reports. According to a notice on the ... Ethicon pelvic mesh litigation will be held on Wednesday, ... have been filed in the proceeding on behalf of ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast (2010 ... restraints, and opportunities in North America, Europe, Asia, & ... 89 market data tables , ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers ... healthcare IT market is expected to grow from $99.6 ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3
... Inc., a global provider of image management services ... announced that it has made a contribution to ... Vascular Association (AVA). Open the Pathway is an ... M2S has a long-term commitment to vascular treatment ...
... legislators announced a budget deal that includes temporary revenues in ... them permanent, SEIU members and community allies from around the ... in Sacramento and the Governor,s offices in Los Angeles, Riverside, ... week.The rallies are an effort to stop the bad budget ...
... incentivesPORTLAND, Ore., Feb. 11 Regence BlueCross BlueShield of ... the Boys and Girls Clubs of Central Oregon. The ... develop healthy habits and decision making skills, and improve ... impact that our choices have on health, and we,re ...
... better diagnosis, treatment for heart patients , , WEDNESDAY, Feb. ... contrast echocardiography had a significant impact on the diagnosis ... new study found. , Echocardiography bounces sound waves into ... moving heart. If that image isn,t clear enough, it ...
... Program Teaches Earth-Friendly Health ChoicesMIDLAND, Mich., Feb. 11 ... looking for ways to go green. By implementing ... program ( www.HealthEnhancementSystems.com ), Green ... www.greenplanetwellness.com/?from=nw_021109 ), participants learn small steps ...
... Calif., Feb. 11 Valeant Pharmaceuticals International (NYSE: ... a conference call on Tuesday, February 24, 2009 at ... for the 2008 fourth quarter and year.The dial-in number ... code 83660030. International callers should dial ...
Cached Medicine News:Health News:M2S, Inc. Makes Contribution to American Vascular Association 2Health News:M2S, Inc. Makes Contribution to American Vascular Association 3Health News:Boys and Girls Clubs of Central Oregon Get $10K Regence Grant 2Health News:Study Brings Value of Echocardiography Into Focus 2Health News:Green Planet Wellness Helps Employers Have Big Environmental Impact 2Health News:Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009 2
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...
(Date:5/17/2013)... /PRNewswire-iReach/ -- United Medical Education, a company that provides ... Advanced Life Support (PALS) and Basic Life Support (BLS), ... online course manuals. In order to gain access ... an account with the company. By offering the free ... Education is setting a precedent among similar companies. ...
(Date:5/17/2013)... , May 17, 2013  Serving a region of ... Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... therapy capabilities with the acquisition of an Elekta Versa HD™ ... Versa HD offers clinicians the versatility to deliver conventional therapies ... while also enabling treatment of highly complex cancers that require ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... a First, Immunotherapy Works Against Neuroblastoma-- PHILADELPHIA, May 28 ... for an experimental therapy using elements of the body,s ... neuroblastoma, a challenging cancer of the nervous system.John M. ... of Philadelphia, co-authored the phase 3 clinical trial, which ...
... Survival, Disease Control and Neurotoxicity Data To Be ... Support Picoplatin as a Neuropathy-Sparing Alternative to Oxaliplatin ... Management Team to Host Analyst and Investor Briefing ... SOUTH SAN FRANCISCO, Calif., May 28 Poniard ...
Cached Medicine Technology:New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer 2New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: